| Year |
Citation |
Score |
| 2023 |
Qin Y, Walters AA, Rouatbi N, Wang JT, Abdel-Bar HM, Al-Jamal KT. Evaluation of a DoE based approach for comprehensive modelling of the effect of lipid nanoparticle composition on nucleic acid delivery. Biomaterials. 299: 122158. PMID 37243988 DOI: 10.1016/j.biomaterials.2023.122158 |
0.592 |
|
| 2022 |
Qin Y, Walters AA, Al-Jamal KT. Plasmid DNA cationic non-viral vector complexes induce cytotoxicity-associated PD-L1 expression up-regulation in cancer cells in vitro. International Journal of Pharmaceutics. 122481. PMID 36513254 DOI: 10.1016/j.ijpharm.2022.122481 |
0.71 |
|
| 2022 |
Ghochani Y, Muthukrishnan SD, Sohrabi A, Kawaguchi R, Condro MC, Bastola S, Gao F, Qin Y, Mottahedeh J, Iruela-Arispe ML, Rao N, Laks DR, Liau LM, Mathern GW, Goldman SA, et al. A molecular interactome of the glioblastoma perivascular niche reveals integrin binding sialoprotein as a mediator of tumor cell migration. Cell Reports. 41: 111511. PMID 36261010 DOI: 10.1016/j.celrep.2022.111511 |
0.323 |
|
| 2022 |
Qin Z, Cao H, Ni C, Han L, Wang R, Blasig R, Haseloff R, Qin Y, Lan J, Lou X, Ma P, Yao X, Wang L, Wang F, Zhu L, et al. Claudin-12 deficiency inhibits tumor growth by impairing transendothelial migration of myeloid-derived suppressor cells. Cancer Research. PMID 35580275 DOI: 10.1158/0008-5472.CAN-21-3896 |
0.336 |
|
| 2021 |
Walters AA, Santacana-Font G, Li J, Routabi N, Qin Y, Claes N, Bals S, Tzu-Wen Wang J, Al-Jamal KT. Nanoparticle-Mediated Molecular Reprogramming of Immune Checkpoint Interactions for Cancer Immunotherapy. Acs Nano. PMID 34677938 DOI: 10.1021/acsnano.1c04456 |
0.744 |
|
| 2021 |
Abdel-Bar HM, Walters AA, Lim Y, Rouatbi N, Qin Y, Gheidari F, Han S, Osman R, Wang JT, Al-Jamal KT. An "eat me" combinatory nano-formulation for systemic immunotherapy of solid tumors. Theranostics. 11: 8738-8754. PMID 34522209 DOI: 10.7150/thno.56936 |
0.517 |
|
| 2020 |
Ma P, Qin Y, Cao H, Erben U, Ni C, Qin Z. Temporary blockade of interferon-γ ameliorates doxorubicin-induced cardiotoxicity without influencing the anti-tumor effect. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 130: 110587. PMID 32763819 DOI: 10.1016/j.biopha.2020.110587 |
0.311 |
|
| 2020 |
Qu D, Qin Y, Liu Y, Liu T, Liu C, Han T, Chen Y, Ma C, Li X. A Fever-inducible Lipid Nanocomposite for Boosting Cancer Therapy through Synergistic Engineering of Tumor Microenvironment. Acs Applied Materials & Interfaces. PMID 32575984 DOI: 10.1021/acsami.0c06949 |
0.332 |
|
| 2020 |
Qin Y, Liu T, Guo M, Liu Y, Liu C, Chen Y, Qu D. Mild-heat-inducible sequentially released liposomal complex remodels the tumor microenvironment and reinforces anti-breast-cancer therapy. Biomaterials Science. PMID 32555847 DOI: 10.1039/d0bm00498g |
0.306 |
|
| 2019 |
Guo M, Qu D, Qin Y, Chen Y, Liu Y, Huang M, Chen Y. Transferrin-Functionalized Microemulsions Coloaded with Coix Seed Oil and Tripterine Deeply Penetrate To Improve Cervical Cancer Therapy. Molecular Pharmaceutics. PMID 31663764 DOI: 10.1021/acs.molpharmaceut.9b00717 |
0.351 |
|
| 2019 |
Wu H, Han Y, Rodriguez Sillke Y, Deng H, Siddiqui S, Treese C, Schmidt F, Friedrich M, Keye J, Wan J, Qin Y, Kühl AA, Qin Z, Siegmund B, Glauben R. Lipid droplet-dependent fatty acid metabolism controls the immune suppressive phenotype of tumor-associated macrophages. Embo Molecular Medicine. e10698. PMID 31602788 DOI: 10.15252/emmm.201910698 |
0.387 |
|
| 2018 |
Qu D, Wang L, Qin Y, Guo M, Guo J, Huang M, Liu Y, Liu C, Li H, Chen Y. Non-triggered sequential-release liposomes enhance anti-breast cancer efficacy of STS and celastrol-based microemulsion. Biomaterials Science. PMID 30346001 DOI: 10.1039/c8bm00796a |
0.321 |
|
| 2017 |
Qu D, Guo M, Qin Y, Wang L, Zong B, Chen Y, Chen Y. A multicomponent microemulsion using rational combination strategy improves lung cancer treatment through synergistic effects and deep tumor penetration. Drug Delivery. 24: 1179-1190. PMID 28841044 DOI: 10.1080/10717544.2017.1365394 |
0.367 |
|
| Show low-probability matches. |